ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR518/008/SRR5181678/SRR5181678.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR518/001/SRR5181681/SRR5181681.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR518/009/SRR5181679/SRR5181679.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR518/005/SRR5181675/SRR5181675.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR518/006/SRR5181676/SRR5181676.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR518/007/SRR5181677/SRR5181677.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR518/003/SRR5181673/SRR5181673.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR518/000/SRR5181680/SRR5181680.fastq.gzprimaryOK200GenomicsMicrobiology, Rutgers Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA362195Mus musculusPurpose The aim of this study is to find out the difference of gene expression by immunization with the pep27 mutant vaccine. Method After immunization with the pep27 mutant vaccine, mRNA was extracted from lung and spleen. Result Both B and T cells were activated by the pep27 mutant vaccine. Overall design: mRNA profiles of immunized group in lung and spleen were compared to the non-immunized group.xref:PubMed:29579238ENAfalseMus musculusHigh-throughput sequencing after immunization with pep27 mutant2025-09-242020-01-18PRJNA362195GSE937181009029579238